The global vascular stent market is expected to register a CAGR of around ~7% over the period of 2021-2027. This is mainly due to the rise in the prevalence of the rising geriatric population coupled with aortic diseases around the globe. Moreover, the increase in demand for non-invasive surgical procedures is widening the scope of growth for the vascular stent market. Moreover, stringent government regulations coupled with the growing focus of major stakeholders in the healthcare industry is fueling the market growth. The advancements in medical technology and the introduction of a variety of stents are the important factors that drive the market of the vascular stent market. Moreover, the changing lifestyle preferences have significantly increased the diseases such as diabetes and obesity that are responsible for increasing cardiac disorders. As a result, the growing burden of aortic diseases is facilitated the vascular stent market growth across the globe.

Access a Sample copy of the report browse through – https://univdatos.com/get-a-free-sample-form-php/?product_id=28711

Based on the product, the market is categorized as a coronary stent, peripheral stent, EVAR stent grafts, and others. The coronary stent segment held a significant share in the market of the vascular stent. The advancements in medical technology and the introduction of a variety of stents are the important factors that drive the market for coronary stents. Furthermore, the increasing geriatric population coupled with the rising prevalence of heart diseases in them spurs the market size of the vascular stent. As per CDC, 17% of adults aged above 65 years have coronary heart disease and 7.6% of them have faced a stroke. Moreover, the changing lifestyle preferences have significantly increased the diseases such as diabetes and obesity that are responsible for increasing cardiac disorders also contributing to the significant market share of the vascular stent.

For a detailed analysis of the global vascular stent market browse through – https://univdatos.com/report/vascular-stent-market/

Based on the mode of delivery, the market is segmented into balloon-expandable stents and self-expanding stents. The balloon-expandable stents are expected to have a significant market share in the vascular stent market during the forecast period. This is mainly due to the usage of advanced materials in it along with the frequent product launches by major players. For instance, in September 2021, ivascular company launched iCover. It is a new generation BX-covered stent made of CoCrL605 with three tantalum radiopaque markers at each end. CoCr alloy stents can reach higher radial despite the decreased metal burden.

Access a Sample copy of the report browse through – https://univdatos.com/get-a-free-sample-form-php/?product_id=28711

For a better understanding of the market adoption of the vascular stents, the market is analyzed based on its worldwide presence in the countries such as North America (US, Canada, Rest of North America); Europe (Germany, UK, France, Italy, Spain, and Rest of Europe); Asia-Pacific (China, Japan, India, Australia, Rest of Asia-Pacific), and Rest of World. North America is expected to witness significant growth during the forecast period on account of the growing various cardiovascular diseases and medical treatment activities in countries like the U.S. and Canada. North America constitutes a significant market for artificial intelligence (AI) in the medical diagnostics industry due to the presence of better healthcare and diagnostic infrastructure along with higher healthcare investments. An estimated, around 18 million Americans aged 20 and above have heart disease and nearly 650,000 Americans die of heart disease each year. Furthermore, the presence of well-established market players and frequent product launches in the region is also a contributing factor to the growth of the vascular stent market.

Abbott, Medtronic, Boston Scientific Corporation, Terumo Corporation, B Braun Melsungen AG, Biotronik, Stentys SA, MicroPort Scientific Corporation, C. R. Bard, Inc., and Cook Medical are some of the key players operating in the global Vascular stent market. Several M&As along with partnerships have been undertaken by these players to develop various types of Vascular stent devices.

For a detailed analysis of the global vascular stent market browse through – https://univdatos.com/report/vascular-stent-market/

Global Vascular stent Market Segmentation

Market Insight, by Product

  • Coronary Stent
  • Peripheral Stent
  • EVAR Stent Grafts
  • Others

Market Insight, by Type

  • Bare-metal Stents
  • Drug-eluting Stents
  • Bioabsorbable Stents

Market Insight, by Mode of Delivery

Market Insight, by End-Users

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Others

Market Insight, by Region

  • North AmericaUnited States
  • Canada
  • Rest of North America
  • EuropeFrance
  • Germany
  • Italy
  • Spain
  • United Kingdom
  • Rest of Europe
  • Asia-PacificChina
  • India
  • Australia
  • Japan
  • Rest of Asia-Pacific
  • Rest of World

Top Company Profiles

  • Abbott
  • Medtronic
  • Boston Scientific Corporation
  • Terumo Corporation
  • B Braun Melsungen AG
  • Biotronik
  • Stentys SA
  • MicroPort Scientific Corporation
  • C. R. Bard Inc.
  • Cook Medical